Stay updated on Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    New and updated dates were added to the study record, including recent last-update timestamps, and key timeline dates such as the primary completion date and study completion date. These changes reflect updates to the trial's schedule and reported progress, providing current milestones for enrollment and results timelines.
    Difference
    0.2%
    Check dated 2026-05-04T02:10:21.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page’s UI/release revision label was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T15:44:03.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T14:16:48.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Added revision label v3.5.0 and removed revision label v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T20:15:35.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This is a non-functional update that does not change study content or user interactions.
    Difference
    0.0%
    Check dated 2026-03-07T13:10:43.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Added Principal Investigator Julie Specht, MD and updated the recruiting contact at The Christ Hospital Cancer Center. Expanded the study locations to 15 sites, including Cincinnati, Ohio.
    Difference
    0.6%
    Check dated 2026-02-28T06:54:51.000Z thumbnail image

Stay in the know with updates to Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab + Pembrolizumab in Metastatic TNBC Clinical Trial page.